Share this post on:

product name VUF 10166


Description: VUF10166 is a novel, potent and competitive antagonist for 5-HT3A receptor with Ki of 0.04 nM, its affinity at 5-HT3AB receptor is significantly lower. VUF10166 shows low activity to 5-HT3AB receptor with Ki of 22 nM. VUF10166 may be used to can distinguish between 5-HT3A and 5-HT3AB receptors. VUF10166 has no activity to α7 nACh receptor.

References: J Pharmacol Exp Ther. 2012 May;341(2):350-9.



Molecular Weight (MW)

262.74 
Formula

C13H15ClN4 
CAS No.

155584-74-0 
Storage

-20℃ for 3 years in powder form
-80℃ for 2 years in solvent
Solubility (In vitro)

DMSO: 21 mg/mL (79.9 mM) 
Water: <1 mg/mL
Ethanol: 61 mg/mL (232.2 mM) 
Solubility (In vivo)

 
Synonyms

 

other peoduct :

In Vitro

In vitro activity: VUF10166 shows low activity to 5-HT3AB receptor with Ki of 22 nM. VUF10166 may be used to can distinguish between 5-HT3A and 5-HT3AB receptors. VUF10166 has no activity to α7 nACh receptor. VUF10166 also acts as a partial agonist at 5-HT3A receptors with EC50 of 5.2 μM, which shows that VUF10166 is unlikely to bind in the receptor pore.


Kinase Assay:


Cell Assay

In Vivo  
Animal model  
Formulation & Dosage  
References J Pharmacol Exp Ther. 2012 May;341(2):350-9. 

EPZ031687

Share this post on:

Author: Sodium channel